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Abstract
The purpose of the present study was to investigate the interaction between H2S and NO
(nitric oxide) in the kidney and to evaluate its impact on the functional contribution of α1A
and α1B-adrenoreceptors subtypes mediating the renal vasoconstriction in the kidney of
rats with left ventricular hypertrophy (LVH). In rats the LVH induction was by isoprenaline
administration and caffeine in the drinking water together with intraperitoneal administration
of H2S. The responsiveness of α1A and α1B to exogenous noradrenaline, phenylephrine and
methoxaminein the absence and presence of 5-methylurapidil (5-MeU) and chloroethylclo-
nidine (CEC) was studied. Cystathione gamma lyase (CSE), cystathione β synthase (CBS),
3-mercaptopyruvate sulphar transferase (3-MST) and endothelial nitric oxide synthase
(eNOS) were quantified. There was significant up regulation of CSE and eNOS in the LVH-
H2S compared to the LVH group (P<0.05). Baseline renal cortical blood perfusion (RCBP)
was increased (P<0.05) in the LVH-H2S compared to the LVH group. The responsiveness
of α1A-adrenergic receptors to adrenergic agonists was increased (P<0.05) after administra-
tion of low dose 5-Methylurapidil in the LVH-H2S group while α1B-adrenergic receptors
responsiveness to adrenergic agonists were increased (P<0.05) by both low and high dose
chloroethylclonidine in the LVH-H2S group. Treatment of LVH with H2S resulted in up-regu-
lation of CSE/H2S, CBS, and 3-MST and eNOS/NO/cGMP pathways in the kidney. These
up regulation of CSE/H2S, CBS, and 3-MST and eNOS/NO/cGMP pathways enhanced the
responsiveness of α1A and α1B-adrenoreceptors subtypes to adrenergic agonists in LVH-
H2S. These findings indicate an important role for H2S in modulating deranged signalling in
the renal vasculature resulting from LVH development.
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Introduction
Left ventricular hypertrophy (LVH) is characterized by adrenoreceptor over stimulation and
sympatho-excitation. The levels of circulating noradrenaline and mean discharge frequency in
peripheral sympathetic nerves [1–3] have been reported to be elevated in hypertensive LVH
patients. The degree of increased sympathetic activity is proportional to the mass of LV in
LVH [4]. Interestingly, renal denervation using the percutaneous technique results in a regres-
sion in heart mass and function in LVH patients with a sympatho-inhibition [5]. The hyper-
sympathetic activity in LVH is associated with vascular dysfunction and impairment of α1-
adrenoceptor-mediated renal vasoconstriction[6]. The association of α1-adrenoceptors with
sympathetic hyperactivity has also been observed in other physiological and pathological states
[7,8].
Hydrogen sulphide (H2S) is an endothelial derived relaxing factor (EDRF)[9], which is pro-
duced endogenously from two sulphur containing amino acids, L-cysteine and L-methionine
by the enzymes cystathionine γ lyse (CSE) and cystathionine β synthase (CBS) [10,11] and acts
on KATPase channels [12]. In mice H2S is produced in proximal tubules of kidney [13–15],
endothelial cells [16] and vascular smooth muscle [12]. Recently enzymes like 3 MST(3-mer-
captopyruvate sulphar transferase) along with cystein amino transferase (CAT), which is simi-
lar to aspartate amino transferase [17] have also been observed to produce H2S in brain [18].
Recent studies have shown expression of CSE, CBS and 3-MST enzymes in the kidney [19].
H2S provides renal protection under ischemia reperfusion injury [20], chronic renal failure
[21] and also plays an important role in controlling renal tubular and vascular functions [22].
We previously reported blunt responses of α1D-adrenoreceptors to adrenergic stimuli in the
kidney of rats with LVH [23], and association of down regulation of CSE and eNOS with
decreased responsiveness of α1A-adrenoreceptors to adrenergic stimuli in the kidney [24].
Gases like NO and H2S have important roles in normal physiological states as well as in dis-
eases and also have an interdependent production [25–29]. H2S has been observed to be
responsible for NO production in smooth muscles [30,31], while others have shown that NO
enhanced the up regulation of H2S production in the plasma [32,33].
Despite extensive research on the therapeutic potential of H2S in the renal vasculature,
potential interactions of H2S with α1-adrenoceptors under normal physiological conditions
and in LVH state remained unexplored. Therefore in the present study we tested the hypothesis
that "CSE/H2S, CBS, 3-MST and eNOS/NO pathways are down regulated in the kidney of
LVH rats and responsible for the blunted responses of α1A-adrenoreceptors to adrenergic sti-
muli." We further hypothesized that "up-regulation of the CSE/H2S, CBS and 3-MST pathway
by exogenous administration of H2S would increase the renal vascular responsiveness to α1A
and α1B-adrenoceptor activation in the kidneys of LVH rats," in addition" exogenous adminis-
tration of H2S would not only up-regulate the CSE/H2S pathway but also will modulate the
eNOS/NO/cGMP pathway in the kidney to increase the sensitivity of the α1A and α1B-adreno-
ceptorsby augmentation of responses to adrenergic stimuli."
Materials and Methods
Study groups and methodology
The study had been approved by the Animal Research and Service Centre (ARASC) under the
Animal Ethics Committee, Universiti Sains Malaysia (AECUSM) with approval no./2012/(76)
(364). Male Wistar-Kyoto (WKY) rats (body wt.200±10g) were obtained from the animal
house of Universiti Sains Malaysia and given free access to tap water and standard chow (Gold
Coin Sdn. Bhd., Penang, Malaysia). Animals were divided into two main groups; one for renal
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functional study and another for molecular expression studies. One main group consisted of 8
subgroups for functional study of α1-adrenoceptors subtypes. The renal functional study group
consisted of Control-5MeU, LVH-5MeU, Control-H2S+5MeU and LVH-H2S+5MeU groups
for α1A-adrenoceptor evaluation while there were Control-CEC, LVH-CEC, Control-H2S
+CEC and LVH-H2S+CEC (n = 6) for assessment of α1B-adrenoceptor functionality. Similarly,
the molecular study groups, consisted of Control, LVH, Control-H2S and LVH-H2S for quanti-
fication of CSE and eNOS mRNA expression (3 animals recruited in each group and each ani-
mal had triplicate therefore total n = 9 for one group), where by renal cortical tissue was taken
for measurement of CSE and eNOS mRNA expression.
LVH was induced by a modification of an earlier model [34] using 5 injections of isoprena-
line (5mg/kg s.c) on days 1, 4, 7, 10 and 13 respectively, while caffeine was given in the drinking
water (62mg/L) for the 2 weeks time as reported from the same lab [23]. The control group
were given 5 saline injections at similar intervals as in the LVH group. H2S treatment involved
the administration of intraperitoneal NaHS (56μM) daily for 5 weeks [35], beginning three
weeks prior to the isoprenaline and caffeine administration.
Expression profiling of CSE, CBS, 3-MSTand eNOS of H2S treated
control and LVH rats’ kidney
Molecular study was conducted as described previously [36]. Briefly the protocol consisted of
the following steps; after cervical dislocation of the rat, kidney cortex was immediately pre-
served in RNAlater1 Solution (Ambion, Life technologies, USA), while RNaseZap1 (ambion,
Life technologies, USA) was used to prevent any contamination. TRIzole reagent (Ambion,
Life technologies, USA) was used to extract total RNA as per manufacturer guidelines. After
homogenization, washing and elution, total RNA was extracted, optimized and quantified for
purity and yield respectively using a microplate reader (Bio Tek Instrument. Inc., VT, USA).
Total RNA was converted to cDNA by High Capacity RNA-to-cDNA kit (Applied Biosys-
tems™, USA), using Step One Plus RT-PCR (Applied Biosystems, Singapore).
The TaqMan primers and probes (TaqMan1-Gene Expression assays (Applied
Biosystems, USA) used were as follows: (1) CSE (Gen Bank accession No. NM_017074.1
and Rn00567128_m1) gene [37]; (2) CBS (Gen Bank accession No. NM_012522.2
and Rn00560948_m1) gene [19]; (3) 3-MST (Gen Bank accession No. NM_138843.1 and
Rn00593744_m1) gene [19]; (4) eNOS (Gen Bank accession No. NM_021838.2 and
Rn02132634_s1) gene [38,39]; (5) β-actin (Gen Bank accession No. NM_031144.2 and
Rn00667869_m1) gene [40,41].
Quantitative RT-PCR reactions were carried out on 3 experimental animals of one group
(3x4 = 12 animals), while each rat was further analysed in triplicate using kidney cortex. Beta actin
was used as an internal control. The relative quantification of target gene CSE and beta actin, com-
parative CT (threshold cycle) method with arithmetic formula (2
-ΔΔCT) was applied [42].
CSE activity in cardiac tissue of control, LVH, control-H2S and LVH-H2S
groups
Kidney tissue CSE activity was measured by a method described previously [10,43]. Briefly the
protocol consisted of homogenization of kidney tissue in 50mmol/L ice cold potassium phos-
phate buffer (pH 6.8). The reaction mixture consisted of 100 mmol/L of potassium phosphate
buffer (pH 7.4), 10mmol/L of L-cysteine, 2mmol/L of pyridoxal 5-phosphate and 10% w/v of
cardiac tissue. Cryo vial tubes each containing 0.5ml of 1% zinc acetate were used as centre
wells to trap the gas. An Erlenmeyer Pyrex flask (25 ml volume) was used for the reaction.
Both, the flask containing reaction mixture and centre wells were flushed with N2 and were
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sealed with paraffin film. The reaction was carried out by initially transferring the reaction
flask from ice to shaking water bath at 37°C. After incubation for 90 minutes 0.5 ml of 50% tri-
chloroacetic acid was added to the reaction mixture to stop the reaction. Flask was sealed again
and incubated at 37°C for 60 minutes to make sure the complete trapping of H2S released from
the reaction mixture. The contents of centre wells were transferred to test tubes each containing
3.5 ml of water. Afterward, 0.5 ml of 20 mmol/L of N, N-2 dimethyl-p-phenylenediamine, sul-
phate in 7.2 mol/L of HCL was added, followed by addition of 0.4 ml of 30 mmol/L of FeCL3 in
1.2 mol/L HCL. Absorbance of the resultant reaction mixture was taken at 670nm. H2S concen-
tration was measured by using standard curve of H2S solutions (3.125–100μM).
H2S measurement in kidney and urine
The H2S measurement in kidney tissue was adapted from a previous report [22]. Briefly, renal
tissue (50 mg) was homogenized in 0.5 ml of 1% zinc acetate and mixed with 0.5 ml of borate
buffer (pH 10.01). After this, a volume of 0.5 ml of N, N-2 dimethyl -p-phenylenediamine
(20mM) and 0.5 ml of 300mM FeCL3 were added to the tissue homogenate. Reaction tubes
were immediately sealed and incubated for 30 minutes with shaking at 37°C. After incubation,
all the samples were centrifuged and absorbance of resultant supernatant layer was measured
at 670 nm. H2S concentration was measured by constructing the standard curve by using
known concentrations (3.125–100μM) of NaHS as standard. Concentration of H2S in the urine
was also measured by following the same method reported for plasma H2S measurement [35].
NO and cGMP level measurements in kidney
The concentration of nitric oxide (nitrite/nitrate) in tissues was determined using a laboratory kit
(NJJC Bio Inc., Nanjing, China) following manufacturer's protocol. The cGMPmeasurements
were done using cGMP Direct Immunoassay Kit (Abcam). The main steps during the procedure
involved sample preparation, standard curve preparation, acetylation was optional one but it was
performed, followed by quantification of cGMP and measurement of optical density at 450 nm.
Agonists and antagonists used in experiment
The present study used 3 agonists noradrenaline (NA), phenylephrine (PE) and methoxamine
(ME). Noradrenaline (NA, Sanofi Winthrop, Surrey, UK) is a non-selective α adrenergic ago-
nist which acts on α1 and α2 adrenergic receptor; methoxamine (ME, Wellcome, London, UK)
is a relatively selective agonist for α1A adrenoreceptors [7,44]; phenylephrine (PE, Knoll, Not-
tingham, UK) has the ability to act non-selectively on α1A, α1B and α1D adrenoceptors [7].
Present study used 2 adrenergic antagonists 5-methylurapidil and choloroethylclonidine
(CEC). The 5 methylurapidil (Research Biochemicals International, Natick, MA, USA) is a rel-
atively selective antagonist for the α1A-adrenoceptor subtype [45]; chloroethylclondine
(Research Biochemicals International, Natick, MA, USA) is a relatively selective antagonist for
the α1B-adrenoreceptor subtype [46]. Sodium chloride (Sigma-Aldrich, UK).
Acute experiment
Overnight fasted rats were anesthetized using 60mg/kg pentaobarbitone intraperitoneally
(Nembutal; CEVA Sante Animale, Libourne, France). Tracheotomy was performed to facilitate
the breathing throughout the experiment. The carotid artery was cannulated (Portex, Kent,
UK) and the cannula was attached to a pressure transducer (Gould P23 ID; Statham Instru-
ments) connected to a PowerLab data acquisition system for continuous monitoring of sys-
temic hemodynamics. The left jugular vein was also cannulated (Portex, Kent, UK) to permit
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the infusion of maintenance doses of anesthesia when required. The left kidney was exposed
through an abdominal incision and a laser Doppler flow probe (ADInstrument) was placed
superficially onto the surface of the kidney cortex for the renal cortical blood perfusion mea-
surements [47]. The iliac artery was cannulated (Portex, Kent, UK) by inserting the cannula up
to the level of the renal artery in such a way that adrenergic agonists were directly delivered to
the renal artery [35,48,49]. The animals were allowed a stabilization period of at least 1 hour
before the onset of vasoconstrictor experiment. During this period of stabilization mean arte-
rial pressure (MAP), systolic blood pressure (SBP) were measured as LVH markers. Later at
the end of experiment and LV index was measured to observe the induction of LVH and effect
of H2S on the regression of LVH.
Acute vasoconstrictor study
The acute renal vasoconstrictor study was performed following the procedure reported earlier
[48–51]. NA, PE and ME were infused intra-renally in increasing and decreasing dosage levels
in such a way that net response was calculated as the average of the increasing and decreasing
doses. NA was given in 25, 50, 100 and 200 ηg; PE was administered as 0.25, 0.50, 1 and 2 μg
and ME was administered as 0.25, 0.50, 1 and 2 μg [7,23,50]. Fresh solutions were prepared
daily. Experiments were divided into 3 phases consisting of a saline phase, low dose antagonist
phase and high dose antagonist phase. In the saline phase, saline was infused into the kidney at
a rate of 6ml/kg/h; in the low dose phase the antagonists were given as a bolus dose 5μg/kg fol-
lowed by a maintenance dose of 1/4th the bolus dose per h (MeU and CEC bolus dose of 5μg/kg
and 10μg/kg intra-renally followed by 1.5μg/kg/h and 1.5μg/kg/h; CEC at 5mg/kg followed by
1.25mg/kg/h) during the ascending and descending doses of adrenergic agonists.
Histopathology of control, LVH, control-H2S and LVH-H2S rat kidney
The right kidney was extracted and preserved in 10% formalin for histopathology study follow-
ing embedding, trimming and sectioning and LV tissue underwent staining with hematoxyllin
and eosin staining [37].
Statistical analysis
The renal vasoconstrictor response to each agonist was taken as the mean of ascending and
descending responses due to four doses. The comparison between the groups was based on the
overall response calculated as the average of the four averaged responses. The data were pre-
sented as mean ± S.E.M. The statistical analysis for the renal vasoconstrictor studies was done
by using one-way ANOVA followed by Bonferroni post hoc test for bar graph data of overall
mean % drop in RCBP, while two-way ANOVA followed by Bonferroni post hoc test for dose
response curves of renal vasoconstrictor study was performed using GraphPad Prism (Graph-
Pad Software, Inc. CA, USA) with significance taken at P< 0.05. Gene expression data were
analysed using the comparative method (ΔΔCT method) and StepOne™ Software (Version 2.1,
Applied Biosystem, USA).
Results
Effect of exogenous administered NaHS on SBP, MAP, heart and LV
index and RCBP in control and LVH groups
SBP, MAP and LV index were significantly increased (P<0.05) in LVH when compared to
Control group, while exogenous administration of H2S significantly (P<0.05) reduced them
(Table 1). However, the RCBP in LVH group was lower (P<0.05) than control (LVH vs.
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control, 94±6 vs. 150±12 bpu). NaHS treatment in the LVH group resulted in a significant
increase (P<0.05) in blood perfusion to the renal cortex compared to their untreated counter-
parts (132±5 vs. 94±6 bpu; Fig 1).
H2S, NO and cGMP levels in kidney tissue and H2S in urine of NaHS
treated and untreated LVH and controls
The concentration of H2S in the kidney tissue of LVH rats was significantly (P<0.05) lower
than the control (LVH vs. control, 24±2 vs. 38±1nM/g of protein) but treatment of LVH rats
with NaHS resulted in a significantly higher level of H2S compared to the untreated LVH rats
(LVH-H2S vs. LVH,67±2 vs. 24±2 nM/g of protein; Fig 2A). Similarly, the concentration of
NO of the kidney tissues in LVH rats was also lowered compared to the control (14±1 vs. 25
±1μmol/g protein) but raised (22±1 μmol/g protein, P<0.05)following NaHS treatment com-
pared to the untreated LVH rats (Fig 2B).
The cGMP levels of the kidney tissues in LVH rats was also lowered compared to the control
(21±1 vs. 39±2fmol/mg protein), but it was higher in those LVH rats that were treated with
NaHS (50±1 fmol/mg protein, P<0.05; Fig 2C).
Table 1. The SBP, MAP heart index and LV index of control, LVH, control-H2S and LVH-H2S.
Parameters Control LVH Control-H2S LVH-H2S
SBP (mmHg) 132±4 159±5* 140±7# 135±2#
MAP (mmHg) 119±1 142±5* 122±6# 122±3#
LV index (%) 0.16±0.004 0.24±0.002* 0.19±0.006*# 0.21±0.001*#
All the data is expressed as mean± SEM.
* P<0.05 represents comparison with control group.
# P<0.05 represents comparison with LVH group.
SBP, systolic blood pressure; MAP, mean arterial pressure; LV, Left ventricle.
doi:10.1371/journal.pone.0154995.t001
Fig 1. Renal cortical blood perfusion in Control, LVH, Control-H2S and LVH-H2S groups.Data are
expressed as mean± SEM. * represents P<0.05 compared to Control while # represents P<0.05 compared to
LVH group (n = 6).
doi:10.1371/journal.pone.0154995.g001
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The concentration of H2S in the urine of LVH rats was significantly (P<0.05) greater than
the control (LVH vs. control, 18±1 vs. 28±1 μmol) but treatment of LVH rats with NaHS
resulted in a significantly higher level of H2S in the urine as compared to the untreated LVH
rats (LVH-H2S vs. LVH, 45±4 vs. 18±1μmol; Fig 2D).
Relative CSE, CBS, 3-MST, eNOS expression and CSE activity in NaHS
treated and untreated control and LVH rats
LVH resulted in down regulation of CSE approximately74%, of CBS around 62%, of 3-MST
approximately 37% and of eNOS by79% in the kidney when compared to CSE, CBS, 3-MSTand
eNOS mRNA in the kidney of control rats. The treatment of control or LVH rats with NaHS
resulted in upregulation of the CSE mRNA in the kidney by approximately 67% and 42.8%
Fig 2. (A, B, C and D). Data showing the concentration of H2S (A) NO (B), cGMP (C) in the kidney and H2S in urine (D) of Control, LVH, Control-
H2S and LVH-H2S groups. Data are expressed as mean± SEM. * represents P<0.05 compared to Control while # represents P<0.05 compared to
LVH group (n = 6).
doi:10.1371/journal.pone.0154995.g002
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respectively (Fig 3A), CBS by approximately 49% and 22.9% (Fig 3B), and that of 3-MST
expression by 30% and 98% respectively (Fig 3C), when compared to their untreated
counterparts.
Upon NaHS treatment of control and LVH rats there was an upregulation of the eNOS
mRNA in the kidney by approximately 46.6% and 21.4% respectively (Fig 3D). However, the
CSE activity in the rat kidney of LVH group was significantly (P<0.05) reduced compared to
CSE activity in the control group, while exogenous administration of H2S significantly increased
(all P<0.05) CSE activity in the kidney of control-H2S and LVH-H2S (CSE activity (nmol/L/g
Prot/min); control: 48±1; LVH: 23±1; control-H2S: 88±1 and LVH-H2S: 74±1; Fig 3E).
Vasoconstrictor responses
α1A-adrenoceptor subtype responses to adrenergic agonists. The magnitude of the renal
vasoconstrictor responses to NA and ME but not PE in LVH rats were significantly (all
P<0.05) blunted compared to their control counterparts (LVH vs. Control, NA; 30±1 vs. 45
±3%, ME; 32±1 vs. 44±2%). The exogenous administration of NaHS resulted in augmented
vasoconstrictor responses to NA but not to ME or PE (LVH-H2S vs. LVH, 36±1 vs. 28±1%; Fig
4A, 4B & 4C).
The renal vasoconstrictor responses to NA in the saline phase in the LVH-H2S group were
significantly (P<0.05) increased by 29% when compared to LVH group. Following blockade of
the α1A-adrenoceptor with low doses of 5-MeU, the renal vasoconstriction elicited by α1A-
adrenoceptor activation by exogenous administration of NA in the LVH-H2S group was signif-
icantly (P<0.05) increased by 44% when compared to that in the LVH group. Blocking the
α1A-adrenoceptor with the high dose of 5-MeU, caused the response elicited by α1A-adreno-
ceptor with exogenous administration of NA in the LVH-H2S group to be increased by 17%
when compared to that in the LVH group but the magnitude of these responses was not signifi-
cantly different (Figs 4A & 5A). The dose response curves of different doses of NA in Control,
LVH, Control-H2S and LVH-H2S in the absence and presence of 5-MeU are shown in Fig 5A.
Induction of LVH significantly (P<0.05) reduced the renal vascular responses to the α1A-
adrenoceptoragonist PE in the saline phase by 38% when compared to those obtained to PE in
the saline phase of the control group. The exogenous administration of H2S to LVH augmented
the renal vascular responses to PE, the α1A-adrenoceptor agonist, in the saline phase by 22%.
Blocking α1A-adrenoceptorsusing low doses of 5-MeU, caused the renal vasoconstrictor
responses elicited by the exogenous administration of PE to the LVH-H2S group to be signifi-
cantly (P<0.05) increased by 42% when compared to those obtained in the LVH group. By
contrast, there was no significant increase in renal vascoconstrictor responses to PE when the
α1A-adrenoceptor was blocked with the high doses of 5-MeU (Figs 4B and 5B). The dose
response curves of different doses of PE in Control, LVH, Control-H2S and LVH-H2S in the
absence and presence of 5-MeU are shown in Fig 5B.
Induction of LVH significantly (P<0.05) reduced renal cortical blood perfusion when ME
was given in the saline phase by 41%, when compared to those obtained in the saline phase of
control group, while exogenous administration of H2S had no effect on responses to ME in
saline phase of LVH. Blocking the α1A-adrenoceptor using low doses of 5-MeU, significantly
(P<0.05) increased the renal vasoconstrictor responses elicited by ME by 41% in the LVH-H2S
group when compared to the LVH group during the low dose phase. There was no significant
change in the magnitude of the renal vascular responses to ME when the adrenoreceptor was
blocked with high doses of 5-MeU Fig 4C. The dose response curves of different doses of ME
in Control, LVH, Control-H2S and LVH-H2S in the absence and presence of 5-MeU are shown
in Fig 5C).
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α1B-adrenoceptor subtype responses to adrenergic agonists. Induction of LVH signifi-
cantly (P<0.05) reduced the renal vasoconstrictor responses to NA in the saline phase by 35%
when compared to responses to NA in saline phase of control group. The renal vasoconstrictor
responses to NA in the saline phase of LVH-H2S were significantly (P<0.05) increased by 82%
when compared to the LVH group. Blocking the α1B-adrenoceptor using low doses of CEC,
caused the renal vascular responses elicited by NA in the LVH-H2S group to be significantly
(P<0.05) increased by 11.6% when compared to those produced by NA in the LVH group.
Blocking the α1B-adrenoceptor using high doses of CEC, significantly (P<0.05) increased the
renal vascular responses to exogenous NA by 85% compared to those obtained in the LVH
group although this was not significant when compared to the administration of NA in the
control group (Fig 6A). This showed that exogenous administration of H2S in LVH group sig-
nificantly (P<0.05) increased the renal vascular responses produced by NA in the saline, low
and high dose phases of antagonists when compared to responses to NA in saline, low dose
and high dose phases of antagonists in the LVH group Fig 6A while the dose response curves
of different doses of NA in control, LVH, control-H2S and LVH-H2S in the absence and pres-
ence of CEC are shown in Fig 7A.
Induction of LVH significantly (P<0.05) reduced the renal vascular responses PE in the
saline phase by 47% when compared to control group. The renal vasoconstrictor responses to
PE in saline phase of LVH-H2S were significantly (P<0.05) increased by 91% when the same
responses were compared in the LVH group. Blocking the α1B-adrenoceptor with low doses of
CEC, the renal vascular responses elicited by PE in the LVH-H2S group were significantly
(P<0.05) increased by 10.4% when compared to LVH group. Moreover, when the high doses
of CEC were given, the renal vasoconstrictor responses PE in LVH-H2S group were increased
significantly (P<0.05) by 71% compared to those produced by PE in the LVH group (Fig 5B).
This showed that exogenous administration of H2S in the LVH group significantly (P<0.05)
enhanced the renal vasoconstrictor responses produced by the α1B-adrenoceptor to PE in the
saline, low dose and high dose phases of antagonist when compared to responses produced to
PE in saline, low dose and high dose phases of antagonists in LVH rats (Fig 6B). Dose response
curves of different doses of PE in Control, LVH, Control-H2S and LVH-H2S in the absence
and presence of CEC are shown in Fig 7B.
Induction of LVH significantly (P<0.05) reduced the renal vascular responses to ME in the
saline phase by 36% compared to those obtained in saline phase of the corresponding control
group. The renal vasoconstrictor responses to ME in saline phase of LVH-H2S were signifi-
cantly (P<0.05) increased by 73% when compared to those obtained in the LVH group. Block-
ing the α1B-adrenoceptor using the low doses of CEC, significantly (P<0.05) increased by 89%
the renal vasoconstrictor responses elicited by ME in LVH-H2S group compared to those
obtained in the LVH group. During the high doses of CEC, the renal vasoconstrictor responses
to ME in the LVH-H2S group were increased significantly (P<0.05) by 11.3% compared to
those produced by ME in the LVH group (Fig 5C). This showed that exogenous administration
of H2S in the LVH group significantly (P<0.05) increased the renal vascular responses pro-
duced by α1B-adrenoceptor activation by ME in the saline low dose and high dose phases of
antagonist when compared to those to ME in same phases of the LVH group (Fig 6C). The
dose response curves of different doses of ME in Control, LVH, Control-H2S and LVH-H2S in
the absence and presence of CEC are shown in Fig 7C.
Fig 3. (A, B, C, D and E). Data showing the expression of CSEmRNA (A), CBSmRNA (B), 3-MSTmRNA (C), eNOSmRNA (D) and CSE activity
(E) in the kidney of Control, LVH, Control-H2S and LVH-H2S groups. Data are expressed as mean± SEM. * represents P<0.05 compared to
Control while # represents P<0.05 compared to LVH group (n = 9 in triplicate).
doi:10.1371/journal.pone.0154995.g003
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Fig 4. (A, B and C). Bar graph showing the overall mean of % drop in renal cortical blood perfusion in response to NA (A), PE (B) and ME (C) in
Control, LVH, Control-H2S and LVH-H2S groups rats during saline, 5-MeU low dose and 5-MeU high dose phases. Values are mean± SEM of n = 6
rats in each group. * P<0.05 vs. Saline phase of same group and # P<0.05 vs. 5-MeU low dose phase of same group. ϕ P<0.05 vs. respective
phase of Control andΨ P<0.05 vs. respective phase of LVH groups.
doi:10.1371/journal.pone.0154995.g004
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Fig 5. (A, B and C). Dose response curve of renal vasoconstriction responses to set of doses of NA (A), PE (B) and ME (C) in Control, LVH, Control-H2S
and LVH-H2S groups rats during saline phase, low dose phase and high dose phase of 5-MeU. Values are mean± SEM of n = 5–7 rats in each group. The
significance is overall mean of 4 graded doses (each dose response is averaging the ascending and descending order responses) of an agonist in each
phase and compared to saline phase and high dose phase. * P<0.05 vs. Saline phase and # P<0.05 vs. 5-MeU low dose phase.
doi:10.1371/journal.pone.0154995.g005
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Fig 6. (A, B and C). Bar graph showing the overall mean of % drop in renal cortical blood perfusion in response to NA (A), PE (B) and
ME (C) in Control, LVH, Control-H2S and LVH-H2S groups rats during saline, CEC low dose and CEC high dose phases. Values are
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mean± SEM of n = 6 rats in each group. * P<0.05 vs. Saline phase of same group and # P<0.05 vs. CEC low dose phase of same
group. ϕ P<0.05 vs. respective phase of Control andΨ P<0.05 vs. respective phase of LVH groups.
doi:10.1371/journal.pone.0154995.g006
Fig 7. (A, B and C). Dose response curve of renal vasoconstriction responses to set of doses of NA (A), PE (B) and ME (C) in Control, LVH, Control-H2S and
LVH-H2S groups rats during saline phase, low dose phase and high dose phase of CEC. Values are mean± SEM of n = 5–7 rats in each group. The
significance is overall mean of 4 graded doses (each dose response is averaging the ascending and descending order responses) of an agonist in each
phase and compared to saline phase and high dose phase. * P<0.05 vs. Saline phase and # P<0.05 vs. CEC low dose phase.
doi:10.1371/journal.pone.0154995.g007
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Histopathological evidences
Histopathological examination of kidney did not show any abnormality related to tubules and
glomerulus, in addition there were no signs of inflammation, hyaline cast or fibrosis in
LVH-WKY groups (Fig 8A–8D).
Discussion
The present study was based on investigation of the interaction between the gasotransmitter
H2S and α1A and α1B-adrenoceptors in the renal vasculature in LVH rat model and also
explored the hypothesis that (i) exogenous administration of H2S would regulate the eNOS/
NO/cGMP pathway in the kidney which in synergism with H2S could also increase the renal
vascular sensitivity to α1A and α1B-adrenoceptor activation in the LVH rats; (ii) whether exoge-
nous administration of H2S would interact and upregulate the eNOS/NO/cGMP pathway in
control and disease conditions. The first major finding was an upregulation of the CSE/H2S
Fig 8. Histopathological evidence of rat kidney of Control, LVH, Control-H2S and LVH-H2S groups using hematoxyllin and eosine staining.
doi:10.1371/journal.pone.0154995.g008
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pathway in the kidney following exogenous administration of NaHS. This was associated with
an increased sensitivity of the renal vasculature to α1A and α1B-adrenoceptors activation as in
the in LVH rats, the sensitivity of these agonists was blunted. Treatment of LVH rats with
NaHS resulted in enhancement of not only the CSE/H2S pathway but also modulated the
eNOS/NO/cGMP pathway which was associated with an increased sensitivity of the renal vas-
cular α1A and α1B-adrenoceptors to exogenously administered adrenergic agonists.
Increased SBP, MAP and LV index in response to model induction in present study is in
line with our previous study on this model [52]. Exogenous administration of H2S significantly
restored the manifestation of LVH pointing out antihypertrophic role of H2S which has also
been recently reported [36]. The exogenous administration of NaHS in LVH rats increased the
blunted renal cortical blood perfusion. This is similar to the findings in spontaneously hyper-
tensive rats (SHR) whereby exogenous H2S donor increased the baseline renal cortical blood
perfusion [53]. It is possible that in this model, the lower renal cortical blood perfusion in LVH
may be due to an increased local vasoconstriction within the kidney due to the elevated circu-
lating noradrenaline as well as angiotensin II levels [23,54–56], or it may be the local action of
the H2S in the cortex of kidney of LVH rats treated with H2S. It is also possible that the vasodi-
lator effect of H2S could offset the vasoconstrictor action of both factors and reduce the
increased vascular tone in the kidney. This notion is supported by a previous study which dem-
onstrated that exogenous administration of H2S resulted in greater pre-glomerulus arteriolar
vasodilation and resulted in increased GFR and renal blood flow [22]. Local vasodilation by
H2S in the kidney can be evidenced by the upregulation of CSE, CBS and 3-MST mRNAs in
the renal cortex of NaHS treated LVH rats. In addition it was also surprising that exogenous
administration of H2S donor significantly increased the expression of CSE, CBS and 3-MST
mRNAs in the renal cortex which is in accordance with recently reported data [19]. The up-
regulation of CSE, CBS and 3-MST expression in the cortex pointed towards the augmented
local production of H2S, which may have negative impact on the CSE activity as reported [57].
While investigating CSE/H2S pathway in the kidney in the present study, it was observed that
upon increased CSE activity in the kidney, there was also a corresponding increase in H2S con-
centration, thus indicating H2S production in the kidney. The elevated H2S levels may cause
poisoning in brain, however elevated H2S levels in the urine indicated that there is no H2S
accumulation in the plasma. Estimation of thiosulphate level would have resolved the possibil-
ity of H2S toxicity [58], but this was the limitation of the present study. However, it is possible
that this upregulation of CSE/H2S in the kidney may reduce renal vascular tone via vasodilator
pathways which modify the functional behaviour of α1-adrenoceptors which are desensitized
in LVHmodel [23]. Therefore, it can be deduced that enhancement in renal cortical blood per-
fusion in LVH-H2S is due to augmented CSE expression in the cortex along with upregulated
CBS and 3-MST, increased CSE activity and corresponding increase in H2S concentration in
the kidney.
The magnitude of the renal vasoconstrictor responses to NA, PE and ME was lower in the
saline or pre-drug phase of LVH when compared to those produced in the control group in the
present study. It therefore indicated a possible modulation of α1A adrenoreceptor’s function in
the kidney of LVH, which is in accordance with previous studies on α1 adrenoreceptor’s function
in the kidney of LVH rats [23,24]. The blunted response to adrenergic agonists observed in LVH
in the present study is associated with a down regulation of CSE/H2S and eNOS/NO pathways in
the kidney of such animal models [23]. The up-regulation of CSE/H2S pathway in the kidney of
LVH rats upon exogenous administration of the substrate NaHS, an H2S donor and consequent
augmentation of the renal vascular responses to NA, PE and ME, indicated an action of H2S to
produce a vasodilation or reduction in vascular tone which was potent enough to modulate the
vasoconstrictor responses. This however was the case when α1A-adrenoreceptors are partially
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blocked. These augmented responses showed a possible interaction between H2S and α1A adre-
noreceptors which may exist in the renal vasculature but the exact mechanism of action is still
unclear, however possibly it is due to the modification of G-protein coupled 2nd messenger path-
way or up regulation of α1A and α1B-adrenoreceptors.
The present findings supported the view that there could be a shift in the functional contri-
bution of the α1A-adrenoreceptor subtype towards the α1B-adrenoreceptor subtype which was
also observed in previous studies using the same LVHmodel [23]. In addition increased
responsiveness of α1B-adrenoreceptors to NA, PE and ME may be attributed to the local vaso-
dilation in the kidney by the upregulation of CSE/H2S and eNOS/NO/cGMP pathways, which
is supported by a previous study in which α1B-adrenoreceptor subtype mediated the renal vaso-
constriction in a rat model of chronic renal disease induced with cisplatin [59]. The interaction
between H2S and α1B-adrenoreceptors is unknown, but it might be explained by a potentiating
effect of H2S on the responsiveness of these receptors to NA, PE and ME in present model of
LVH by modulation of the eNOS/NO/cGMP pathways. This notion is supported by the fact
that H2S stimulated vasodilatation are dependent on CGMP [60]. Moreover, it is expected that
up regulated eNOS/NO/cGMP pathways would reduce the vascular tone by vasodilation in the
kidney. Another possible reason for the augmented responses to α1B-adrenoreceptor activation
in the LVH-H2S group may be the buffering effect of H2S against elevated levels of the vasocon-
strictor angiotensin II [61] as H2S has ACE inhibitor activity[62]. This enhanced responsive-
ness could also be attributed to the increased expression of CSE mRNA in the kidney cortex
observed in present study which could ultimately lead to an elevated regional concentration of
H2S.
There are few possibilities for decrease in vasoconstriction responses of α1 adrenoreceptors
in LVH which may be due to either down regulation of CSE and eNOS mRNAs expression
[24], desensitization of the receptors [6,63] or alteration in G-protein system due to hyperactiv-
ity of the sympathetic nervous system. This hyperactive sympathetic nervous system elicits
physiological responses mediated by G-protein coupled adrenergic receptors [64] which use a
guanylyl cyclase pathway. The blunt responses of α1A and α1B-adrenoreceptors upon activation
by NA, PE and ME in LVHmay be explained on the basis of increased vascular tone in the kid-
ney due to continuous exposure to vasoconstriction, down regulation of vasodilator pathways,
modification of G-protein coupled 2nd messenger pathway system and reduced expression of
adrenergic receptors in the kidney. The present study also evaluated the vasodilator CSE/H2S
and eNOS/NO/cGMP pathways in the kidney and demonstrated that exogenous administra-
tion of NaHS as a substrate up-regulated the CSE/H2S pathway in the kidney. The novel find-
ing of the present study is the modulation of the eNOS/NO pathways in both normal and
disease state, where the increased eNOS/NO levels in the kidney indicated that exogenous
administration of NaHS result in an up-regulation of the eNOS/NO pathway which being a
vasodilator pathway could reduce vascular tone in the kidney. These findings can be vindicated
by other study that showed that induction of LVH by the administration of isoprenaline and
caffeine result in an increased plasma concentration of vasoconstrictors noradrenaline and
angiotensin II levels and down regulation of CSE mRNA in the heart [37]. Up-regulation of
CSE mRNA expression in the kidney can offset the responses produced by these vasoconstric-
tors which may be the contributory factor for reduced responsiveness of α1-adrenoreceptors.
The present study also showed that H2S donor not only up-regulated CSE/H2S pathway in the
kidney but also up-regulated other H2S producing enzymes like CBS and 3-MST. These up-
regulated H2S producing enzymes are expected to overcome the vasoconstriction being
induced by noradrenaline and angiotensin II as reported in previous study [37], and increased
the responsiveness of α1A and α1B adrenoreceptors in the kidney. The increased CSE activity in
the kidney in LVH-H2S group indicated the significance of interaction between H2S and
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Fig 9. Mechanism of action of hydrogen sulphide in resensitization of α1- adrenoreceptors by modifying the G-protein coupled 2nd
messenger pathway.
doi:10.1371/journal.pone.0154995.g009
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responsiveness of α1-adrenoreceptors subtypes, which had also been observed previously
where blunted response to adrenergic agonists in LVH was associated with a down regulation
of CSE/H2S and eNOS/NO pathways in the kidney of these animal models [23]. The exact way
by which CSE/H2S axis reduced the vascular tone in the kidney is not known yet but it might
be due to the activation of ATP-sensitive potassium channels [26]. The KATP channels are
physiologically the primary target for adenylate cyclase/cAMP/protein kinase A signalling
pathway [65] and this ATP-sensitive potassium channel may cause vasorelaxation by increas-
ing the cAMP pathway [66] (Fig 9). In the present study when we investigated whether cGMP
levels were elevated in the kidney tissue of LVH group treated with H2S compared to control
which would be consistent with the upregulation of eNOS/NO/cGMP pathway. The observa-
tion that in LVH cGMP levels was increased following NaHS is consistent with previous studies
which reported the impact of exogenous administration of H2S which increased the CGMP
pathway by inhibiting Phosphodiestrase [60,67]. These findings support a previously reported
study which showed CSE/H2S mediated vasodilation and smooth muscle relaxation via a cyclic
guanylyl monophosphate pathway in an independent manner [12] being operated by a G-pro-
tein coupled second messenger pathway system. This modulation of the G-protein system may
be one of the reasons for augmentation of the responses of α1 adrenoreceptor activation which
are operated via G-protein[64]. The increased cGMP mediated by NO due to exogenous
administration of NaHS and H2S generation also prevents the degradation of cGMP by inhibit-
ing the phosphodiestarases 5 (PDE-5) [68]. This up-regulation of eNOS/NO/cGMP pathway
in synergy with CSE/H2S would not only increase the vasodilation but also modify the G-pro-
tein coupled 2nd messenger pathway system responsible for augmented responsiveness of α1A
and α1B-adrenoreceptors. The increased NO production following exogenous administration
of NaHS and H2S has been the subject of investigation over the last decade [26,29,69]. We have
shown from molecular and ex-vivo evidence that exogenous administration of NaHS to
increase H2S endogenously upregulated the eNOS/NO/cGMP pathways in the kidney of nor-
mal and LVH rats. However, the exact mechanism by which H2S augmented the responses of
α1A and α1B-adrenoreceptors to these adrenergic agonists could not be defined but it may pos-
sibly be explained on the basis of the upregulation of CSE/H2S and eNOS/NO/cGMP pathways
in the kidney. Furthermore, exogenous administration of NaHS to increase endogenous H2S
modulates the eNOS/NO/cGMP pathways in the kidney in both normal and disease states.
However, future work is required on the expression of these α1A and α1B-adrenoreceptors
mRNAs to observe whether exogenous administration merely improved the responsiveness of
these adrenoreceptors or whether there is up-regulation of respective mRNAs.
Conclusion
In conclusion, in the present study the treatment of LVH with H2S resulted in up-regulation of
CSE/H2S pathway, increased CSE activity and eNOS/NO/cGMP pathways in the kidney. These
up-regulations of CSE/H2S and eNOS/NO/cGMP pathways enhanced the responsiveness of
α1A and α1B-adrenoreceptors subtypes to adrenergic agonists in LVH-H2S. These findings
indicate an important role of H2S in modulating deranged signalling in the renal vasculature
resulting from the development of LVH.
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